Covid Treatment

• Paxlovid slashed severe outcomes for at-risk patients after Omicron surge, study finds

  Canadians at risk of severe illness from COVID-19 who took Paxlovid had a significantly lower risk of being hospitalized or dying as a result of the virus, a new study shows.

  Health

  Feb 13, 2023
  
• Compound made with B.C. sea sponge offers clues into COVID-19 treatment: UBC

  The three most effective compounds come from a sea sponge in Howe Sound, a marine bacteria in Barkeley Sound, and a marine bacteria from Newfoundland.

  Science

  Jan 9, 2023
  
• Advertisement
• What is COVID-19 rebound and when does it happen? Here’s what we know

  President Joe Biden tested positive for COVID-19 a third time after taking an anti-viral drug treatment, but an expert says "rebound" cases are not an unheard phenomenon.

  Health

  Aug 5, 2022
• Advertisement
• U.S. doctors reconsider use of Pfizer’s COVID-19 pill for lower-risk patients

  Paxlovid's emergency authorization stipulates that it should be used only for newly infected people with risk factors, but doctors said many others have sought out a prescription.

  Health

  May 28, 2022
• What immunocompromised Canadians need to know amid rising COVID-19 cases

  A lead physician at the Mississauga Medical Arts said immunocompromised people need to know what tools there are available to them to combat COVID-19 before they get sick.

  Health

  Apr 20, 2022
• Could Paxlovid help treat long COVID? Here’s what we know

  Reports of two patients who found relief from long COVID after taking Pfizer's antiviral Paxlovid provide evidence for clinical trials to help those suffering, experts say.

  Health

  Apr 18, 2022
• Guidelines released for who can receive Paxlovid treatment for COVID-19 in Ontario

  Ontario is prioritizing older, unvaccinated residents and immunocompromised individuals for a new antiviral COVID-19 treatment.

  Health

  Jan 27, 2022
• U.S. limits use of Regeneron, Eli Lilly COVID-19 antibody treatments amid Omicron spread

  Last month, the U.S. had paused the distribution of Regeneron and Lilly's treatments and said the halt would continue until new data emerges on their efficacy against Omicron.

  Health

  Jan 24, 2022
• Advertisement
• Canadian officials hopeful COVID-19 treatments will help ease strain on hospitals

  A new study suggests the antiviral medication remdesivir could have a “modest but significant effect” on COVID-19 patient outcomes.

  Canada

  Jan 20, 2022
• Advertisement
• Pfizer’s COVID pill is in short supply. Should unvaccinated be prioritized?

  "Paxlovid is just yet another piece of the puzzle that helps us manage this illness in people who may be at more risk," said Dr. Gerald Evans of the new COVID-19 treatment.

  Health

  Jan 18, 2022